Sections
Title | Starting Page | Number of Pages |
---|
Table of Contents | 2 | 26 |
List of Tables | 24 | 3 |
List of Figures | 27 | 1 |
Introduction | 28 | 1 |
Global Markets Direct Report Coverage | 28 | 1 |
Malaria Overview | 29 | 1 |
Therapeutics Development | 30 | 2 |
Pipeline Products for Malaria Overview | 30 | 1 |
Pipeline Products for Malaria Comparative Analysis | 31 | 1 |
Malaria Therapeutics under Development by Companies | 32 | 5 |
Malaria Therapeutics under Investigation by Universities/Institutes | 37 | 4 |
Malaria Pipeline Products Glance | 41 | 3 |
Late Stage Products | 41 | 1 |
Clinical Stage Products | 42 | 1 |
Early Stage Products | 43 | 1 |
Malaria Products under Development by Companies | 44 | 7 |
Malaria Products under Investigation by Universities/Institutes | 51 | 7 |
Malaria Companies Involved in Therapeutics Development | 58 | 63 |
4SC AG | 58 | 1 |
Acetylon Pharmaceuticals, Inc. | 59 | 1 |
Actelion Ltd | 60 | 1 |
Agilvax Inc | 61 | 1 |
Akshaya Bio Inc. | 62 | 1 |
Allergy Therapeutics Plc | 63 | 1 |
Amura Holdings Limited | 64 | 1 |
Anacor Pharmaceuticals, Inc. | 65 | 1 |
Artificial Cell Technologies, Inc. | 66 | 1 |
AstraZeneca Plc | 67 | 1 |
Bharat Biotech International Limited | 68 | 1 |
Callaghan Innovation Research Ltd. | 69 | 1 |
Carna Biosciences, Inc. | 70 | 1 |
CEL-SCI Corporation | 71 | 1 |
Celgene Corporation | 72 | 1 |
Cellceutix Corporation | 73 | 1 |
Chong Kun Dang Pharmaceutical Corp. | 74 | 1 |
Cilian AG | 75 | 1 |
Daiichi Sankyo Company, Limited | 76 | 1 |
DesignMedix, Inc. | 77 | 1 |
Eisai Co., Ltd. | 78 | 1 |
GenVec, Inc. | 79 | 1 |
Genzyme Corporation | 80 | 1 |
GlaxoSmithKline Plc | 81 | 1 |
Hager Biosciences, LLC | 82 | 1 |
Horizon Pharma Plc | 83 | 1 |
iBio, Inc. | 84 | 1 |
Imaxio SA | 85 | 1 |
Immtech Pharmaceuticals, Inc. | 86 | 1 |
Immunovaccine Inc | 87 | 1 |
IPCA Laboratories Limited | 88 | 1 |
IRBM Science Park SpA | 89 | 1 |
Jenrin Discovery, Inc. | 90 | 1 |
Jomaa Pharma GmbH | 91 | 1 |
Kancera AB | 92 | 1 |
Kymab Limited | 93 | 1 |
Lipocure Ltd. | 94 | 1 |
Lipotek Pty Ltd. | 95 | 1 |
LondonPharma Ltd | 96 | 1 |
Merck &Co., Inc. | 97 | 1 |
Merck KGaA | 98 | 1 |
MerLion Pharmaceuticals Pte Ltd | 99 | 1 |
Microbiotix, Inc. | 100 | 1 |
Mitsubishi Tanabe Pharma Corporation | 101 | 1 |
Mucosis B.V. | 102 | 1 |
Mymetics Corporation | 103 | 1 |
Novartis AG | 104 | 1 |
PaxVax, Inc. | 105 | 1 |
Pfenex Inc. | 106 | 1 |
Pfizer Inc. | 107 | 1 |
Protein Potential, LLC | 108 | 1 |
Rodos BioTarget GmbH | 109 | 1 |
Sanaria Inc. | 110 | 1 |
Sanofi | 111 | 1 |
SBI Pharmaceuticals Co., Ltd. | 112 | 1 |
Selecta Biosciences, Inc. | 113 | 1 |
Sigma-Tau S.p.A. | 114 | 1 |
Takeda Pharmaceutical Company Limited | 115 | 1 |
Telormedix SA | 116 | 1 |
Tomegavax, Inc. | 117 | 1 |
VLP Biotech, Inc. | 118 | 1 |
VLP Therapeutics, LLC | 119 | 1 |
Zydus Cadila Healthcare Limited | 120 | 1 |
Malaria Therapeutics Assessment | 121 | 12 |
Assessment by Monotherapy Products | 121 | 1 |
Assessment by Combination Products | 122 | 1 |
Assessment by Target | 123 | 3 |
Assessment by Mechanism of Action | 126 | 3 |
Assessment by Route of Administration | 129 | 2 |
Assessment by Molecule Type | 131 | 2 |
Drug Profiles | 133 | 251 |
(aminolevulinic acid hydrochloride + sodium ferrous citrate) Drug Profile | 133 | 1 |
(artenimol + piperaquine) Drug Profile | 134 | 1 |
ACT-451840 Drug Profile | 135 | 1 |
Alaremycin Drug Profile | 136 | 1 |
AN-13762 Drug Profile | 137 | 1 |
AN-6426 Drug Profile | 138 | 1 |
AN-8432 Drug Profile | 139 | 1 |
Antibodies for Malaria Drug Profile | 140 | 1 |
AQ-13 Drug Profile | 141 | 1 |
artefenomel Drug Profile | 142 | 1 |
artefenomel + ferroquine Drug Profile | 143 | 1 |
artemether Drug Profile | 144 | 2 |
AX-05 Drug Profile | 146 | 1 |
BDM-I Drug Profile | 147 | 2 |
BIX-01294 Drug Profile | 149 | 1 |
BKSE-36 Drug Profile | 150 | 1 |
BPH-703 Drug Profile | 151 | 1 |
bromophycolide A Drug Profile | 152 | 1 |
CDRI-99/411 Drug Profile | 153 | 1 |
CEL-1000 Drug Profile | 154 | 2 |
cipargamin Drug Profile | 156 | 1 |
CWHM-123 Drug Profile | 157 | 1 |
CWHM-505 Drug Profile | 158 | 1 |
cysteamine DR Drug Profile | 159 | 8 |
DDD-498 Drug Profile | 167 | 1 |
DLANA-14 Drug Profile | 168 | 1 |
DM-1157 Drug Profile | 169 | 1 |
DSM-265 Drug Profile | 170 | 2 |
DSM-421 Drug Profile | 172 | 1 |
E-209 Drug Profile | 173 | 1 |
E-6446 Drug Profile | 174 | 1 |
EDE-1304 Drug Profile | 175 | 1 |
ELQ-300 Drug Profile | 176 | 1 |
Falcitidin Drug Profile | 177 | 1 |
fosmidomycin Drug Profile | 178 | 2 |
fumarranol Drug Profile | 180 | 1 |
Gene Therapy for Infectious Disease, Gastrointestinal and Metabolic Disorders Drug Profile | 181 | 1 |
GENZ-644131 Drug Profile | 182 | 1 |
GENZ-644442 Drug Profile | 183 | 1 |
GIBH-117 Drug Profile | 184 | 1 |
GSK-030 Drug Profile | 185 | 1 |
GSK-3191607 Drug Profile | 186 | 1 |
GSK-692 Drug Profile | 187 | 1 |
hypoestoxide Drug Profile | 188 | 1 |
IMX-313-ML Drug Profile | 189 | 1 |
JAIVAC-2 Drug Profile | 190 | 1 |
JAIVAC 1 Drug Profile | 191 | 1 |
JD-3000 Series Drug Profile | 192 | 1 |
KAF-156 Drug Profile | 193 | 1 |
KAI-407 Drug Profile | 194 | 1 |
KNI-10006 Drug Profile | 195 | 1 |
KNI-727 Drug Profile | 196 | 1 |
mAb-5D5 Drug Profile | 197 | 1 |
malaria (virus like particle) vaccine Drug Profile | 198 | 1 |
malaria [strain 7G8] vaccine Drug Profile | 199 | 1 |
malaria [strain FVO] vaccine Drug Profile | 200 | 2 |
malaria [strain Salvador I] vaccine Drug Profile | 202 | 1 |
malaria vaccine Drug Profile | 203 | 2 |
malaria vaccine Drug Profile | 205 | 1 |
malaria vaccine Drug Profile | 206 | 1 |
malaria vaccine Drug Profile | 207 | 1 |
malaria vaccine Drug Profile | 208 | 1 |
malaria vaccine Drug Profile | 209 | 2 |
malaria vaccine Drug Profile | 211 | 1 |
malaria vaccine Drug Profile | 212 | 1 |
malaria vaccine Drug Profile | 213 | 1 |
malaria vaccine Drug Profile | 214 | 1 |
malaria vaccine Drug Profile | 215 | 1 |
malaria vaccine Drug Profile | 216 | 1 |
malaria vaccine Drug Profile | 217 | 1 |
malaria vaccine Drug Profile | 218 | 1 |
malaria vaccine Drug Profile | 219 | 1 |
malaria vaccine Drug Profile | 220 | 1 |
malaria vaccine Drug Profile | 221 | 1 |
malaria vaccine Drug Profile | 222 | 1 |
malaria vaccine Drug Profile | 223 | 1 |
malaria vaccine Drug Profile | 224 | 1 |
malaria vaccine Drug Profile | 225 | 1 |
malaria vaccine Drug Profile | 226 | 1 |
malaria vaccine Drug Profile | 227 | 1 |
malaria vaccine Drug Profile | 228 | 1 |
malaria vaccine Drug Profile | 229 | 1 |
malaria vaccine Drug Profile | 230 | 1 |
malaria vaccine Drug Profile | 231 | 1 |
malaria vaccine Drug Profile | 232 | 1 |
malaria vaccine Drug Profile | 233 | 1 |
malaria vaccine Drug Profile | 234 | 1 |
malaria vaccine Drug Profile | 235 | 1 |
malaria vaccine 1 Drug Profile | 236 | 1 |
malaria vaccine 1 Drug Profile | 237 | 1 |
malaria vaccine 1 Drug Profile | 238 | 1 |
malaria vaccine 1 Drug Profile | 239 | 1 |
malaria vaccine 1 Drug Profile | 240 | 1 |
malaria vaccine 2 Drug Profile | 241 | 7 |
malaria vaccine 2 Drug Profile | 248 | 1 |
malaria vaccine 3 Drug Profile | 249 | 1 |
malaria vaccine 4 Drug Profile | 250 | 1 |
malaria vaccine 5 Drug Profile | 251 | 1 |
malaria vaccine 5 Drug Profile | 252 | 2 |
malaria vaccine 6 Drug Profile | 254 | 1 |
malarial vaccine Drug Profile | 255 | 1 |
MaX-04 Drug Profile | 256 | 1 |
MDN-0104 Drug Profile | 257 | 1 |
methylprednisolone sodium phosphate Drug Profile | 258 | 1 |
ML-276 Drug Profile | 259 | 1 |
MMV-000248 Drug Profile | 260 | 1 |
MMV-253 Drug Profile | 261 | 1 |
MMV-390048 Drug Profile | 262 | 1 |
MS-08 Drug Profile | 263 | 1 |
N-251 Drug Profile | 264 | 1 |
N-89 Drug Profile | 265 | 1 |
NCK-8 Drug Profile | 266 | 1 |
nepodin Drug Profile | 267 | 1 |
neuregulin-1 Drug Profile | 268 | 1 |
NPC-1161B Drug Profile | 269 | 1 |
P-218 Drug Profile | 270 | 1 |
PA-92 Drug Profile | 271 | 1 |
PEV-3 Drug Profile | 272 | 2 |
PEV-3B Drug Profile | 274 | 1 |
PMX-1207 Drug Profile | 275 | 1 |
PMX-207 Drug Profile | 276 | 1 |
PMX-30024 Drug Profile | 277 | 1 |
Polymer for Malaria Drug Profile | 278 | 1 |
PQ-1 Drug Profile | 279 | 1 |
Protein to Inhibit Phospholipase A2 for Malaria Drug Profile | 280 | 1 |
PW-28 Drug Profile | 281 | 1 |
Px-533 Drug Profile | 282 | 1 |
R-21 Drug Profile | 283 | 1 |
RBT-06 Drug Profile | 284 | 1 |
RKA-182 Drug Profile | 285 | 1 |
RRX-001 Drug Profile | 286 | 2 |
S-0110725 Drug Profile | 288 | 1 |
S-0111793 Drug Profile | 289 | 1 |
SJ-733 Drug Profile | 290 | 1 |
Small Molecule 1 for Malaria Drug Profile | 291 | 1 |
Small Molecule 2 for Malaria Drug Profile | 292 | 1 |
Small Molecule 2 to Inhibit CaM Kinase for Malaria Drug Profile | 293 | 1 |
Small Molecule for Malaria Drug Profile | 294 | 1 |
Small Molecule for Malaria Drug Profile | 295 | 1 |
Small Molecule for Malaria Drug Profile | 296 | 1 |
Small Molecule for Malaria Drug Profile | 297 | 1 |
Small Molecule for Malaria Drug Profile | 298 | 1 |
Small Molecule for Malaria Drug Profile | 299 | 1 |
Small Molecule for Malaria and Bacterial Infections Drug Profile | 300 | 1 |
Small Molecule to Inhibit CDPK1 for Malaria Drug Profile | 301 | 1 |
Small Molecule to Inhibit GWT1 Protein for Malaria Drug Profile | 302 | 1 |
Small Molecule to Inhibit Histone Deacetylase for Malaria Drug Profile | 303 | 1 |
Small Molecule to Inhibit Hypoxanthine Phosphoribosyltransferase for Malaria Drug Profile | 304 | 1 |
Small Molecule to Inhibit Kinase for Malaria Drug Profile | 305 | 1 |
Small Molecule to Inhibit Proteasome for Malaria Drug Profile | 306 | 1 |
Small Molecules 1 for Malaria Drug Profile | 307 | 1 |
Small Molecules 2 for Malaria Drug Profile | 308 | 1 |
Small Molecules 3 for Malaria Drug Profile | 309 | 1 |
Small Molecules for Bacterial Infections and Malaria Drug Profile | 310 | 1 |
Small Molecules for Infectious Diseases Drug Profile | 311 | 1 |
Small Molecules for Malaria Drug Profile | 312 | 1 |
Small Molecules for Malaria Drug Profile | 313 | 1 |
Small Molecules for Malaria Drug Profile | 314 | 1 |
Small Molecules for Malaria Drug Profile | 315 | 1 |
Small Molecules for Malaria Drug Profile | 316 | 1 |
Small Molecules for Malaria Drug Profile | 317 | 2 |